Company recognized in “Best Contract Research Organization – Full Service Providers” category
MORRISVILLE, NC, OCTOBER 10, 2016 – Worldwide Clinical Trials (www.worldwide.com), one of the world’s leading, full-service contract research organizations (CROs), has been announced as a finalist in the prestigious 2016 Scrip Awards. Selected in the “Best Contract Research Organization – Full Service Providers” category, Worldwide was chosen by a distinguished panel of life science industry experts, and is included as a finalist among six leading, global CROs.
“We are delighted to have been selected as a finalist in the 2016 Scrip Awards,” said Peter Benton, president and COO at Worldwide Clinical Trials. “To be named a finalist in this prestigious award program demonstrates that the hard work and dedication of our employees – in support of our sponsors – is being recognized across the industry. Across the organziation, we are committed to partnering with our customers, with the goal to have each of our customers feel like our only customer.”
The Scrip Awards, now in its 12th year, is among the most prestigious life sciences industry awards. The “Best Contract Research Organization – Full Service Providers” award acknowledges the critical role CROs play in drug development. The finalists for this award are judged on the full range range of services provided, the quality of relationships built with clients, as well as the innovative patient recruitment strategies that the CRO implements. The winner of the category will be announced at the 2016 Scrip Awards ceremony in November.
For more information on the Scrip Awards, visit http://www.scripawards.com/.
About Worldwide Clinical Trials
Worldwide Clinical Trials employs more than 1,400 professionals around the world, with offices in North and South America, Eastern and Western Europe, Russia and Asia. One of the world’s leading, full-service contract research organizations (CROs), we partner with sponsors in the pharmaceutical and biotechnology industries to deliver fully integrated clinical development and bioanalytical services, extending from first-in-human through phase IV studies. Grounded in medicine and science, we help sponsors move from medical discovery into clinical development and commercialization across a range of therapeutic areas, including neuroscience, cardiovascular diseases, immune-mediated inflammatory disorders (IMID), and rare diseases. For more information, visit www.worldwide.com.
